MEDBOX | Toolbox Paediatrics

World Health Organization (WHO) (2013) C_WHO

Guidelines for the Management of common childhood Illness. 2nd edition These guidelines focus on the management of the major causes of childhood mortality in most developing countries, such as newborn problems, pneumonia, diarrhoea, malaria, meningitis, septicaemia, measles and related conditions, severe acute malnutrition and paediatric HIV/AIDS. It also covers common procedures, patient monitoring and supportive care on the wards and some common surgical conditions that can be managed in small hospitals. A smart phone and tablet application is available from the Apple or Google Play Store. Special attention is drawn to the following sections, which are particulary relevant within the COVID-19 context: Chapter 4: information on cough and difficulty in breathing, pneumonia and bronchiolitis; Chapter 10: information on essential supportive care including feeding, fluid and oxygen provision; Annex 1: information on related practical procedures

Tags: Child Health, Clinical Guidelines, IMCI, Integrated management childhood illnesses, Malaria, Neonatal, paediatrics, Pneumonia, Respiratory Infections, treatment of newborns, App,

Source: https://apps.who.int/iris/rest/bitstream

World Health Organization WHO (2022) C_WHO

The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. No further updates to the previous existing recommendations were made in this latest version. This updated (fifth) version contains 16 new recommendations for the rehabilitation of adults with post COVID-19 condition (see Chapter 24) This updated (fourth) version contains three new recommendations regarding hospitalized patients with severe or critical COVID-1

Tags: clinical care, Treatment, guideline, COVID-19, oxygen, therapy, intubation, hypoxaemic respiratory, long covid, rehabilitiation,

Source: https://apps.who.int/iris/rest/bitstream

Global clinical data platform for severe acute hepatitis of unknown aetiology in children case report form (CRF)

World Health Organization WHO (2022) C_WHO

Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting of anonymized, patient-level data of acute hepatitis of unknown aetiology

Tags: case report, Children, Hepatitis, severe acute hepatitis, COVID-19,

Source: https://apps.who.int/iris/rest/bitstream

Laboratory testing for severe acute hepatitis of unknown aetiology in children: interim guidance, 17 June 2022

World Health Organization WHO (2022) C_WHO

This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national public health authorities involved in the identification and investigation of cases of severe acute hepatitis in children. This document is part of a package of guidance for this event, which includes suggested minimum reporting variables and a clinical Case Report Form support Member States with case investigation and reporting

Tags: severe acute hepatitis, Hepatitis, Children, diagnostic, COVID-19,

Source: https://apps.who.int/iris/rest/bitstream

Episode #71 - COVID-19 vaccines and children

World Health Organization WHO (2022) C_WHO

11 May 2022 What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swaminathan explains in Science in 5

Tags: Vaccination, COVID-19, Children, Video,

Source: https://youtu.be/hmIK-nZ3ukA

Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios

Pan American Health Organisation PAHO (2022) C_WHO

Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático, de laboratorio y de diagnóstico de los Estados miembros y a las autoridades nacionales de salud pública que participan en la identificación e investigación de casos de hepatitis aguda grave en niños

Tags: severe acute hepatitis, Hepatitis, Children, diagnostic, COVID-19,

Source: https://www.paho.org/es/file/110448/down

La COVID-19 chez les enfants et les adolescents : document d’information scientifique, 29 septembre 2021

Organisation Mondiale de la Santé OMS (2021) C_WHO

Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de tests, ce qui a entraîné un nombre moins important de cas identifiés de COVID-19 chez les enfants. Si les enfants présentant des symptômes légers ou inexistants transmettent la maladie, ils peuvent agir comme des vecteurs de transmission au sein de leur communauté. Il est essentiel de comprendre les symptômes, l'infectivité et les modes de transmission du SRAS-CoV-2 chez les enfants et les adolescents pour développer, adapter et améliorer les mesures de contrôle du COVID-19 à tous les âges. Ce document est un résumé des connaissances actuelles concernant l'acquisition et la transmission de l'infection par le SRAS-CoV-2 et les symptômes de la maladie COVID-19 chez les enfants et les adolescents. Il vise à éclairer les décisions, en fonction des contextes locaux, sur la meilleure façon de maintenir ouvertes les écoles, les jardins d'enfants et les crèches et sur les conseils à appliquer en matière de mixité intergénérationnelle

Tags: Children, Adolescents, COVID-19, symtoms, side effects, infection control, transmission, enfants,

Source: https://apps.who.int/iris/bitstream/hand

COVID-19 disease in children and adolescents: Scientific brief, 29 September 2021

World Health Organization WHO (2021) C_WHO

SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in children. If children with mild or no symptoms transmit the disease, they may act as drivers of transmission within their communities. Understanding symptoms, infectivity and patterns of SARS-CoV-2 transmission in children and adolescents is essential for developing, adapting and improving control measures for COVID-19 across all ages. This is a summary of the current knowledge around SARS-CoV-2 infection acquisition and transmission and COVID-19 disease symptoms in children and adolescents. It aims to inform decisions, based on local contexts, on how to best keep schools, kindergarten and day-care facilities open and what advice to apply to intergenerational mixing

Tags: Children, Adolescents, COVID-19, symtoms, side effects, infection control, transmission,

Source: https://apps.who.int/iris/rest/bitstream

Les 5minutes scientifiques-Épisode 42-Les enfants et les vaccins

Organisation Mondiale de la Santé OMS (2021) C_WHO

Transcript Francais

Tags: global data, transmission, COVID-19, update, virus variants, Video,

Source: https://who.canto.global/pdfviewer/viewe

Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2

World Health Organization WHO (2021) C_WHO

The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathogens, feasibility of vertical transmission of SARS-CoV-2, data related to interpretation of positive SARS-CoV-2 virologic and serologic neonatal tests, lessons from diagnosis of other congenital infections, and existing proposed definitions to classify timing of vertical transmission of SARS-CoV-2

Tags: pregnant women, COVID-19, vertical transmission/PMTCT, Neonatal, PMTCT,

Source: https://apps.who.int/iris/rest/bitstream

	Pocket book of hospital care for children World Health Organization (WHO) (2013) C_WHO View PDF(8822) Download (3467) Add to my MEDBOX Guidelines for the Management of common childhood Illness. 2nd edition These guidelines focus on the management of the major causes of childhood mortality in most developing countries, such as newborn problems, pneumonia, diarrhoea, malaria, meningitis, septicaemia, measles and related conditions, severe acute malnutrition and paediatric HIV/AIDS. It also covers common procedures, patient monitoring and supportive care on the wards and some common surgical conditions that can be managed in small hospitals. A smart phone and tablet application is available from the Apple or Google Play Store. Special attention is drawn to the following sections, which are particulary relevant within the COVID-19 context: Chapter 4: information on cough and difficulty in breathing, pneumonia and bronchiolitis; Chapter 10: information on essential supportive care including feeding, fluid and oxygen provision; Annex 1: information on related practical procedures Tags: Child Health, Clinical Guidelines, IMCI, Integrated management childhood illnesses, Malaria, Neonatal, paediatrics, Pneumonia, Respiratory Infections, treatment of newborns, App, Source: https://apps.who.int/iris/rest/bitstream
	Clinical management of COVID-19: Living guideline, 15 September 2022 World Health Organization WHO (2022) C_WHO View PDF(103) Download (105) Add to my MEDBOX The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. No further updates to the previous existing recommendations were made in this latest version. This updated (fifth) version contains 16 new recommendations for the rehabilitation of adults with post COVID-19 condition (see Chapter 24) This updated (fourth) version contains three new recommendations regarding hospitalized patients with severe or critical COVID-1 Tags: clinical care, Treatment, guideline, COVID-19, oxygen, therapy, intubation, hypoxaemic respiratory, long covid, rehabilitiation, Source: https://apps.who.int/iris/rest/bitstream
	Global clinical data platform for severe acute hepatitis of unknown aetiology in children case report form (CRF) World Health Organization WHO (2022) C_WHO View PDF(53) Download (26) Add to my MEDBOX Multiple countries are reporting severe acute cases of hepatitis of unknown aetiology in children, in several regions of the world. WHO has developed this clinical case report form (CRF) to support and facilitate reporting of anonymized, patient-level data of acute hepatitis of unknown aetiology Tags: case report, Children, Hepatitis, severe acute hepatitis, COVID-19, Source: https://apps.who.int/iris/rest/bitstream
	Laboratory testing for severe acute hepatitis of unknown aetiology in children: interim guidance, 17 June 2022 World Health Organization WHO (2022) C_WHO View PDF(56) Download (26) Add to my MEDBOX This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national public health authorities involved in the identification and investigation of cases of severe acute hepatitis in children. This document is part of a package of guidance for this event, which includes suggested minimum reporting variables and a clinical Case Report Form support Member States with case investigation and reporting Tags: severe acute hepatitis, Hepatitis, Children, diagnostic, COVID-19, Source: https://apps.who.int/iris/rest/bitstream
	Episode #71 - COVID-19 vaccines and children World Health Organization WHO (2022) C_WHO Open external link (362) Add to my MEDBOX 11 May 2022 What are WHO's recommendations for COVID-19 vaccines and children? And what does the evidence say so far about the safety of these vaccines in children? And if you live in a country where this vaccination is not available for your kids, how can you keep them safe? WHO’s Dr Soumya Swaminathan explains in Science in 5 Tags: Vaccination, COVID-19, Children, Video, Source: https://youtu.be/hmIK-nZ3ukA
	Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios Pan American Health Organisation PAHO (2022) C_WHO View PDF(45) Download (18) Add to my MEDBOX Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático, de laboratorio y de diagnóstico de los Estados miembros y a las autoridades nacionales de salud pública que participan en la identificación e investigación de casos de hepatitis aguda grave en niños Tags: severe acute hepatitis, Hepatitis, Children, diagnostic, COVID-19, Source: https://www.paho.org/es/file/110448/down
	La COVID-19 chez les enfants et les adolescents : document d’information scientifique, 29 septembre 2021 Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(23) Download (26) Add to my MEDBOX Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de tests, ce qui a entraîné un nombre moins important de cas identifiés de COVID-19 chez les enfants. Si les enfants présentant des symptômes légers ou inexistants transmettent la maladie, ils peuvent agir comme des vecteurs de transmission au sein de leur communauté. Il est essentiel de comprendre les symptômes, l'infectivité et les modes de transmission du SRAS-CoV-2 chez les enfants et les adolescents pour développer, adapter et améliorer les mesures de contrôle du COVID-19 à tous les âges. Ce document est un résumé des connaissances actuelles concernant l'acquisition et la transmission de l'infection par le SRAS-CoV-2 et les symptômes de la maladie COVID-19 chez les enfants et les adolescents. Il vise à éclairer les décisions, en fonction des contextes locaux, sur la meilleure façon de maintenir ouvertes les écoles, les jardins d'enfants et les crèches et sur les conseils à appliquer en matière de mixité intergénérationnelle Tags: Children, Adolescents, COVID-19, symtoms, side effects, infection control, transmission, enfants, Source: https://apps.who.int/iris/bitstream/hand
	COVID-19 disease in children and adolescents: Scientific brief, 29 September 2021 World Health Organization WHO (2021) C_WHO View PDF(51) Download (34) Add to my MEDBOX SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in children. If children with mild or no symptoms transmit the disease, they may act as drivers of transmission within their communities. Understanding symptoms, infectivity and patterns of SARS-CoV-2 transmission in children and adolescents is essential for developing, adapting and improving control measures for COVID-19 across all ages. This is a summary of the current knowledge around SARS-CoV-2 infection acquisition and transmission and COVID-19 disease symptoms in children and adolescents. It aims to inform decisions, based on local contexts, on how to best keep schools, kindergarten and day-care facilities open and what advice to apply to intergenerational mixing Tags: Children, Adolescents, COVID-19, symtoms, side effects, infection control, transmission, Source: https://apps.who.int/iris/rest/bitstream
	Les 5minutes scientifiques-Épisode 42-Les enfants et les vaccins Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(38) Download (32) Add to my MEDBOX Transcript Francais Tags: global data, transmission, COVID-19, update, virus variants, Video, Source: https://who.canto.global/pdfviewer/viewe
	Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2 World Health Organization WHO (2021) C_WHO View PDF(32) Download (23) Add to my MEDBOX The WHO COVID-19 LENS (Living Evidence Synthesis) working group consolidated available evidence, based on rapid reviews of the literature and results of a living systematic review on pregnancy and COVID-19 (up to October 7, 2020), on potential mechanisms of vertical transmission of infectious pathogens, feasibility of vertical transmission of SARS-CoV-2, data related to interpretation of positive SARS-CoV-2 virologic and serologic neonatal tests, lessons from diagnosis of other congenital infections, and existing proposed definitions to classify timing of vertical transmission of SARS-CoV-2 Tags: pregnant women, COVID-19, vertical transmission/PMTCT, Neonatal, PMTCT, Source: https://apps.who.int/iris/rest/bitstream